Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06407232 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Sep 2026 to Aug 2027v9
  2. Secondary endpoints: details revised at 1 of 1 entry
    • Study description shortened, about 111 words
    v8
  3. Re-verified, no change to tracked fieldsv7
  4. Site contact updatedv6
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 2024 to Aug 8, 2024
    • Site details revised
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary and study completion dates: Jun 2026 to Sep 2026
    • Start date: Jul 2024 to Aug 2024
    v4
  2. Start date: Jun 2024 to Jul 2024v3
  3. Start date: May 2024 to Jun 2024v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is designed to assess how effective letermovir is in preventing recurrence of cytomegalovirus (CMV) infection in adult kidney or kidney/pancreas transplant recipients who are UW Health patients. Participants will be in the study for about 6 months.
Trial Details
NCT Number NCT06407232
Lead Sponsor University of Wisconsin, Madison
Collaborators: Merck Sharp & Dohme LLC
Conditions
(from sponsor)		 Cytomegalovirus Infections, Kidney Transplant Infection, Pancreas Transplant
Related terms Cytomegalovirus Infections
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov